Van Ganse E - Search Results

1

Severe hypertriglyceridaemia in patients treated with lipid-modifying agents.

Désaméricq G, Van Ganse E, Schwalm MS, Bourke A, Moulin P. Désaméricq G, et al. Among authors: van ganse e. Diabetes Metab. 2012 Jun;38(3):277-9. doi: 10.1016/j.diabet.2012.02.009. Epub 2012 Apr 11. Diabetes Metab. 2012. PMID: 22498019 No abstract available.

2

Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.

Laforest L, Souchet T, Moulin P, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Van Ganse E. Laforest L, et al. Among authors: van ganse e. Arch Cardiovasc Dis. 2009 Jan;102(1):43-50. doi: 10.1016/j.acvd.2008.06.021. Epub 2009 Jan 25. Arch Cardiovasc Dis. 2009. PMID: 19233108 Free article.

3

Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.

Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, Chretin S, Yin D, Alemao E, de Pouvourville G. Van Ganse E, et al. Atherosclerosis. 2006 Mar;185(1):58-64. doi: 10.1016/j.atherosclerosis.2005.05.036. Epub 2005 Jul 20. Atherosclerosis. 2006. PMID: 16038912 Clinical Trial.

4

Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs.

Laforest L, Moulin P, Schwalm MS, Le Jeunne P, Chretin S, Kitio B, Massol J, Van Ganse E. Laforest L, et al. Among authors: van ganse e. Nutr Metab Cardiovasc Dis. 2007 Nov;17(9):657-65. doi: 10.1016/j.numecd.2006.07.012. Epub 2006 Nov 30. Nutr Metab Cardiovasc Dis. 2007. PMID: 17141490

5

Ineffectiveness of lipid-lowering therapy in primary care.

Van Ganse E, Souchet T, Laforest L, Moulin P, Bertrand M, Le Jeunne P, Travier N, Yin D, Alemao E, de Pouvourville G. Van Ganse E, et al. Br J Clin Pharmacol. 2005 Apr;59(4):456-63. doi: 10.1111/j.1365-2125.2005.02266.x. Br J Clin Pharmacol. 2005. PMID: 15801941 Free PMC article.

6

Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy.

Laforest L, Moulin P, Souchet T, Ritleng C, Desamericq G, Le Jeunne P, Schwalm MS, Kieffer A, Van Ganse E. Laforest L, et al. Among authors: van ganse e. Atherosclerosis. 2008 Aug;199(2):368-77. doi: 10.1016/j.atherosclerosis.2007.11.033. Epub 2008 Jan 11. Atherosclerosis. 2008. PMID: 18191135 Clinical Trial.

7

[Migraine or headache management: a pharmacy survey].

Desamericq G, Revol A, Laforest L, Chamba G, Bauguil G, Ritleng C, Van Ganse E. Desamericq G, et al. Among authors: van ganse e. Therapie. 2009 Nov-Dec;64(6):395-403. doi: 10.2515/therapie/2009057. Epub 2009 Dec 23. Therapie. 2009. PMID: 20025843 French.

8

10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.

Belhassen M, Van Ganse E, Nolin M, Bérard M, Bada H, Bruckert E, Krempf M, Rebours V, Valero R, Moulin P. Belhassen M, et al. Among authors: van ganse e. J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1332-e1342. doi: 10.1210/clinem/dgaa838. J Clin Endocrinol Metab. 2021. PMID: 33221907

9

[No title available]

[No authors listed] [No authors listed] PMID: 34932804

10

Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey.

Laforest L, Van Ganse E, Ritleng C, Desamericq G, Letrilliart L, Moreau A, Rosen S, Mechin H, Chamba G. Laforest L, et al. Among authors: van ganse e. BMC Public Health. 2009 Sep 15;9:337. doi: 10.1186/1471-2458-9-337. BMC Public Health. 2009. PMID: 19754928 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

181 results

Search Page

Filters